Serum Aldolase Isozyme Levels in Patients with Cerebrovascular Diseases
Open Access
- 1 November 1990
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 300 (5) , 291-295
- https://doi.org/10.1097/00000441-199011000-00004
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology (61570297)
This publication has 13 references indexed in Scilit:
- Decreased serum aldolase B levels in patients with malignant tumorsCancer, 1988
- Serum aldolase isoenzymes in benign and malignant liver diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Human aldolase B serum levels: A marker of liver injuryHepatology, 1984
- SUBUNIT-SPECIFIC RADIOIMMUNOASSAY FOR ALDOLASE A, B AND C SUBUNITS: CLINICAL SIGNIFICANCEAnnals of the New York Academy of Sciences, 1983
- Enzymatic changes in serum and cerebrospinal fluid in neurological injuryJournal of Neurosurgery, 1983
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Brain-Type Creatine Kinase IsoenzymeArchives of Neurology, 1977
- Isolation of fructose diphosphate aldolases A, B, and CBiochemistry, 1969
- Distribution of Fructose Diphosphate Aldolase Variants in Biological SystemsBiochemistry, 1969
- ALDOLASE VARIANTS: STRUCTURE AND PHYSIOLOGICAL SIGNIFICANCE*Annals of the New York Academy of Sciences, 1968